Personalized Medicine in Psoriasis: Mindera Health’s Mind.Px Test Changes Physician Behavior, Improves Outcomes
The Dermatology Digest
MAY 13, 2025
Mindera Healths Mind.Px cab help predict the most appropriate biologic drug for a psoriasis patient, reducing the trial-and-error approach to medication selection and improving outcomes, according to results from The MATCH study. The new study, which is published in Dermatology and Therapy , found that the Mind.Px test results altered physician behavior and lead to faster, more effective patient outcomes.
Let's personalize your content